Skip to main content
. 2021 Jan 5;58(2):211–225. doi: 10.3892/ijo.2021.5167

Figure 1.

Figure 1

WST-1 viability assays on SK-N-AS, SK-N-BE(2)-C, SK-N-DZ, SK-N-FI and SK-N-SH cell lines upon treatment with the PI3K inhibitor, BYL719, and FGFR inhibitor, JNJ-42756493. WST-1 viability assay measured the absorbance following treatment for 24, 48 and 72 h of SK-N-AS, SK-N-BE(2)-C, SK-N-DZ, SK-N-FI and SK-N-SH cells with (A-E) PI3K inhibitor, BYL719, and (F-J) FGFR inhibitor, JNJ-42756493. The graphs represent 3 experimental runs per cell line and results are presented as the means ± standard deviation.